Viyash Scientific Limited (BOM:512529)
252.50
-3.10 (-1.21%)
At close: Aug 17, 2026
Viyash Scientific Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 110,207 | 79,956 | 32,686 | 28,649 | 18,037 | 33,033 | |
Market Cap Growth | 151.40% | 144.62% | 14.09% | 58.84% | -45.40% | -43.97% |
Enterprise Value | 114,547 | 84,924 | 37,458 | 33,171 | 22,344 | 35,930 |
Last Close Price | 252.50 | 183.20 | 130.80 | 115.30 | 72.59 | 133.80 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 53.18 | 45.10 | 140.77 | - | - | 80.66 |
Forward PE | 27.41 | 19.59 | 26.97 | 26.97 | 26.97 | 50.49 |
PS Ratio | 3.08 | 2.34 | 1.09 | 2.09 | 1.27 | 2.34 |
PB Ratio | 3.54 | 2.57 | 1.27 | 4.02 | 2.41 | 4.46 |
P/TBV Ratio | 5.67 | 4.11 | 2.29 | 7.96 | 4.62 | 7.47 |
P/FCF Ratio | 58.56 | 42.49 | 13.81 | - | - | - |
P/OCF Ratio | 34.13 | 24.76 | 9.48 | 93.64 | 107.31 | 107.97 |
PEG Ratio | 1.06 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.20 | 2.48 | 1.25 | 2.42 | 1.57 | 2.54 |
EV/EBITDA Ratio | 16.44 | 13.55 | 10.04 | 43.20 | 71.72 | 36.55 |
EV/EBIT Ratio | 23.90 | 20.19 | 24.38 | 142.53 | - | 61.99 |
EV/FCF Ratio | 60.87 | 45.13 | 15.82 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.16 | 0.16 | 0.26 | 0.68 | 0.59 | 0.49 |
Debt / EBITDA Ratio | 0.70 | 0.76 | 1.70 | 5.87 | 11.62 | 3.45 |
Debt / FCF Ratio | - | 2.60 | 2.76 | - | - | - |
Net Debt / Equity Ratio | 0.07 | 0.07 | 0.20 | 0.59 | 0.54 | 0.41 |
Net Debt / EBITDA Ratio | 0.34 | 0.37 | 1.36 | 5.47 | 12.90 | 3.11 |
Net Debt / FCF Ratio | - | 1.22 | 2.14 | -1982.41 | -5.79 | -163.71 |
Asset Turnover | - | 0.78 | 1.06 | 0.89 | 0.95 | 0.99 |
Inventory Turnover | - | 2.22 | 3.02 | 2.27 | 2.47 | 2.66 |
Quick Ratio | - | 1.39 | 0.95 | 0.65 | 0.69 | 0.76 |
Current Ratio | - | 2.38 | 1.78 | 1.31 | 1.41 | 1.53 |
Return on Equity (ROE) | - | 7.91% | 0.96% | -4.05% | -16.38% | 5.90% |
Return on Assets (ROA) | - | 6.00% | 3.39% | 0.95% | -0.64% | 2.55% |
Return on Invested Capital (ROIC) | 9.26% | 8.44% | 7.31% | 2.04% | -1.40% | 4.81% |
Return on Capital Employed (ROCE) | - | 11.40% | 4.90% | 2.50% | -1.60% | 6.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.92% | 2.22% | 0.71% | -1.25% | -6.72% | 1.24% |
FCF Yield | 1.71% | 2.35% | 7.24% | -0.01% | -3.85% | -0.06% |
Payout Ratio | - | - | - | - | - | 30.14% |
Buyback Yield / Dilution | -72.76% | -1.33% | -74.50% | -0.57% | 0.90% | -1.16% |
Total Shareholder Return | -72.76% | -1.33% | -74.50% | -0.57% | 0.90% | -1.16% |